非增强CT联合深度学习检测结直肠癌:多中心国际队列研究
本研究基于两个中心1321例结直肠癌患者和1357例正常对照开发了COCA(AI检测结直肠癌)模型,采用联合病灶分割与分类架构及混合监督学习优化。在六个中心2053例患者的多中心国际验证中,COCA的AUC为0.967至0.996,较放射科医生将敏感性提高20.4%、特异性提高5.4%。
要点
- COCA在非增强CT上检测结直肠癌的多中心验证AUC达0.967–0.996。
- COCA较放射科医生提高敏感性20.4%、特异性5.4%。
- 真实世界队列中COCA敏感性86.6%–88.2%、特异性99.5%–99.8%。
核心结论
- COCA在体检、急诊、门诊和住院等多种临床场景中表现稳健,可有效减少结直肠癌漏诊。
- COCA有望作为大规模机会性结直肠癌筛查的潜在工具。
研究设计与样本
- 回顾性、多中心、国际研究,使用两个中心的1321例结直肠癌患者和1357例正常对照开发COCA。
- 采用联合病灶分割与分类架构,并以混合监督学习优化。
- 外部验证纳入四个中心的腹部和盆腔CT数据及四个中心的胸部CT数据。
- 读者研究纳入10名不同经验水平的放射科医生,先后在无COCA辅助和有COCA辅助下评估非增强CT诊断性能。
主要发现
- 在六个中心2053例患者的多中心国际验证中,COCA检测结直肠癌的AUC范围为0.967至0.996。
- 与放射科医生相比,COCA将结直肠癌检测敏感性提高20.4%、特异性提高5.4%。
- 第一个真实世界多场景验证(9014例连续患者)中,COCA敏感性88.2%、特异性99.5%。
临床怎么用
- COCA可辅助放射科医生在非增强CT上机会性检测结直肠癌,降低漏诊风险。
- COCA适用于体检、急诊、门诊和住院等多种临床场景的结直肠癌筛查。
局限性
- 本研究为回顾性设计。
- 未报告COCA在筛查人群中的前瞻性随机验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Colorectal cancer (CRC) is a leading cause of cancer deaths, with early screening vital to reduce mortality. While methods such as colonoscopy and computed tomography (CT) colonography are available, they face challenges such as bowel preparation, invasiveness, and low adherence. We aimed to develop COCA (COlorectal Cancer detection with AI), a novel, noninvasive, cost-effective, and scalable method for CRC screening using noncontrast CT scans. PATIENTS AND METHODS: This retrospective, multicenter, and international study included 1321 CRC patients and 1357 normal controls from two centers to develop COCA. We enhanced the CRC detection capabilities of COCA by employing a joint lesion segmentation and classification architecture, optimized with mixed-supervised learning. For validation, we gathered abdominal and pelvic CT data from four external centers and chest CT data from four centers. A reader study involving 10 radiologists with varying levels of experience evaluated diagnostic performance on noncontrast CT first without COCA assistance and then with it. Additionally, we evaluated both the initial and iteratively improved versions of COCA in two real-world, multi-scenario cohorts comprising 27 433 consecutive patients. RESULTS: In a multicenter and international validation involving 2053 patients across six centers, COCA demonstrated an area under the curve ranging from 0.967 to 0.996 for CRC detection. COCA improved CRC detection sensitivity by 20.4% and specificity by 5.4% compared with radiologists. In the first real-world multi-scenario validation with 9014 consecutive patients, COCA achieved a sensitivity of 88.2% and specificity of 99.5% for CRC detection. In the second external real-world validation involving 18 419 consecutive patients, COCA maintained a sensitivity of 86.6% and specificity of 99.8%, with a positive predictive value of 63.4%. CONCLUSIONS: COCA demonstrated robust performance across various clinical scenarios, including physical exams, emergency departments, outpatient, and inpatient settings, effectively preventing missed CRC diagnoses. These findings suggest that COCA could serve as a potential tool for large-scale opportunistic CRC screening.
引用
- Chen X, Qiu MY, Zhang JP, et al. Colorectal cancer detection using noncontrast CT and deep learning: a multicenter and international cohort study. Ann Oncol. 2026. PMID: 42025761. doi:10.1016/j.annonc.2026.04.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。